NZ505980A - Beta-sheet mimetics - Google Patents

Beta-sheet mimetics

Info

Publication number
NZ505980A
NZ505980A NZ505980A NZ50598098A NZ505980A NZ 505980 A NZ505980 A NZ 505980A NZ 505980 A NZ505980 A NZ 505980A NZ 50598098 A NZ50598098 A NZ 50598098A NZ 505980 A NZ505980 A NZ 505980A
Authority
NZ
New Zealand
Prior art keywords
beta
protein
sheet
sheet mimetics
same
Prior art date
Application number
NZ505980A
Inventor
Maher N Qaber
Michael S Kahn
John E Tulinsky
Jessymol Mathew
Michael K Mcmillian
Original Assignee
Molecumetics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecumetics Ltd filed Critical Molecumetics Ltd
Priority to NZ505980A priority Critical patent/NZ505980A/en
Priority claimed from PCT/US1998/002891 external-priority patent/WO1999041276A1/en
Publication of NZ505980A publication Critical patent/NZ505980A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Beta -sheet mimetics and methods relating to the same are disclosed. The beta -sheet mimetics have utility as protease and kinase inhibitors, as well as inhibitors of transcription factors and protein-protein binding interactions. Methods of the invention include administration of a beta -sheet mimetic, or use of the same for the manufacture of a medicament for treatment of a variety of conditions associated with the targeted protease, kinase, transcription factor and/or protein-protein binding interaction.
NZ505980A 1998-02-12 1998-02-12 Beta-sheet mimetics NZ505980A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ505980A NZ505980A (en) 1998-02-12 1998-02-12 Beta-sheet mimetics

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1998/002891 WO1999041276A1 (en) 1998-02-12 1998-02-12 β-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF
NZ505980A NZ505980A (en) 1998-02-12 1998-02-12 Beta-sheet mimetics

Publications (1)

Publication Number Publication Date
NZ505980A true NZ505980A (en) 2003-01-31

Family

ID=19928017

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ505980A NZ505980A (en) 1998-02-12 1998-02-12 Beta-sheet mimetics

Country Status (1)

Country Link
NZ (1) NZ505980A (en)

Similar Documents

Publication Publication Date Title
NO990522D0 (en) Use of <beta> -sheet mimetics as protease and kinase inhibitors of transcription factors
YU68002A (en) Modified factor viii
MXPA02012272A (en) Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv.
NO20013443D0 (en) Triazole compounds with dopamine D3 receptor activity
HK1118579A1 (en) Adamts13-comprising compositions having thrombolytic activity
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
DK1091975T3 (en) New cyclosporine with improved activity profile
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
MX2007004936A (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity.
DE60128912D1 (en) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
ES2192764T3 (en) MIMETICS OF LAMINA BETA AND METHODS RELATED TO THE USE OF THE SAME.
MXPA05010414A (en) Use of clusterin for the treatment and/or prevention of peripheral neurological diseases.
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
EE200300129A (en) Use of distamycin alpha-haloacryloyl derivative
HUP0202592A2 (en) Transdermal delivery of lasofoxifene
AU2002365288A1 (en) Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
NZ505980A (en) Beta-sheet mimetics
MXPA05009428A (en) Compositions and methods for preventing and treating endotoxin-related diseases and conditions.
MXPA04001205A (en) Compounds for eliminating and/or relieving anhedonia.
EP1661566A3 (en) Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
DE60215219D1 (en) USE OF DARIFENACINE FOR THE TREATMENT OF THE HARNDRANGS
GR1004434B (en) Use of diflofenac or topically acceptable salt thereof for the treatment of burns
WO2004012732A3 (en) Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)